Ignacio González-García (Ignacio Gonzalez)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Monoclonal Antibody

Particulate Matter

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical pharmacokinetics

MedImmune Ltd

Universitat de València (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

MedImmune Ltd Nov 12o 2018

United Kingdom

Clinical Pharmacokineticist :: Translational Sciences - Clinical Pharmacology, Pharmacometrics and DMPK

Education History

Universitat de València

Spain

PHD

Publications

John Hood, Ignacio González-García, Nicholas White, Leeron Marshall, Vincent F S Dubois, Paolo Vicini, Paul G Baverel
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total. Pharmaceutics 13 (4) (2021)
Carlos Fernández-Teruel, Ignacio González-García, Iñaki F Trocóniz, Rubin Lubomirov, Arturo Soto, Salvador Fudio
Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer. Clinical pharmacokinetics 58 (3) (2020)
Ani S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, Aung Naing, Ashish V Chintakuntlawar, Naiyer A Rizvi, Helen J Ross, Michael Gordon, Philip R Mallinder, Nairouz Elgeioushi, Ignacio González-García, Nathan Standifer, Jennifer Cann, Nicholas Durham, Shahram Rahimian, Rakesh Kumar, Crystal S Denlinger
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)